Text this: 325 | MATCH‐ADJUSTED COMPARATIVE ANALYSIS OF EPCORITAMAB + R‐DHAX/C OR R‐ICE VERSUS R‐DHAX/C OR R‐ICE IN 2L+ TRANSPLANT‐ELIGIBLE PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMA.